Records containing: Myelodysplastic Syndromes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-07-10A Multi-Center, Open Label, Randomized, Active Controlled Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Processed Unrelated Bone Marrow in Patients With Acute or Chronic Leukemia
-
CLINICAL_TRIALS study record update · 2013-07-03PHASE II STUDY OF HIGH DOSE CYTARABINE COMBINED WITH A SINGLE HIGH DOSE OF IDARUBICIN FOR NEWLY DIAGNOSED PATIENTS WITH AML: THE AML-3 PROTOCOL
-
CLINICAL_TRIALS study record update · 2013-06-27Treatment of Children With Down Syndrome (DS) and Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Transient Myeloproliferative Disorder (TMD): A Phase III Group-Wide Study
-
CLINICAL_TRIALS study record update · 2013-06-27BUSULFAN AND CYCLOPHOSPHAMIDE FOR CYTOREDUCTION OF PATIENTS WITH ACUTE AND CHRONIC LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES UNDERGOING ALLOGENEIC BONE MARROW TRANSPLANTATION WHO CANNOT BE TREATED WITH TOTAL BODY IRRADIATION
-
CLINICAL_TRIALS study record update · 2013-06-27Busulfan Dose Escalation Study Based on AUC in the Setting of Busulfan/Fludarabine Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation (HCT)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-06-26A Phase I/II Combination Study of Topotecan, Fludarabine, Cytosine Arabinoside and G-CSF (T-FLAG) Induction Therapy in Patients With Poor Prognosis AML, MDS and Relapsed/Refractory ALL Followed by Maintenance of Either PBSC Transplant or 13 Cis-Retinoic Acid
-
CLINICAL_TRIALS study record update · 2013-06-26A Phase II Study on the Effectiveness of Thalomid (Thalidomide) Combined With Procrit (Erythropoietin) for the Treatment of Anemia in Patients With Low and Intermediate Risk-1 (IPSS Score Less Than or Equal to 1.5) Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2013-06-26Phase II Study With Decitabine (5-aza-2'-Deoxycytidine, DAC) in Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2013-06-25PHASE I DOSE-ESCALATION TRIAL OF YTTRIUM-90-LABELED HuM195 (HUMANIZED ANTI-CD33) IN PATIENTS WITH ADVANCED MYELOID MALIGNANCIES
-
CLINICAL_TRIALS study record update · 2013-06-24Pilot Study of Sodium Phenylbutyrate Plus Azacytidine
-
CLINICAL_TRIALS study record update · 2013-06-21A Centralized Cord Blood Registry to Facilitate Allogeneic, Unrelated Donor Umbilical Cord Blood Transplantation
-
CLINICAL_TRIALS study record update · 2013-06-19An Open-Label, Intravenous To Oral Switch, Multiple Dose, Multi-Center Study To Investigate The Pharmacokinetics, Safety And Tolerability Of Voriconazole In Hospitalized Children Aged 2 - <12 Years Who Require Treatment For The Prevention Of Systemic Fungal Infection
-
CLINICAL_TRIALS study record update · 2013-06-19Phase I Study of Yttrium-90 Labeled HuM195 Combined With Etoposide as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients With Advanced Myelodysplastic Syndrome and Refractory Leukemia
-
CLINICAL_TRIALS study record update · 2013-06-18Music Therapy for Distress During Autologous Stem Cell Transplantation: A Randomized Trial
-
CLINICAL_TRIALS study record update · 2013-06-18A Phase I Study of PS-341 in Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-06-05A Phase I Clinical And Pharmacological Study Of Pyroxamide (NSC 696085) In Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2013-05-16Evaluation of Fludarabine, Busulfan and Alemtuzumab as a Reduced Toxicity Ablative Bone Marrow Stem Cell Transplant Regimen for Children With Stem Cell Defects, Marrow Failure Syndromes, or Myelodysplastic Syndrome (MDS)/Leukemia
-
CLINICAL_TRIALS study record update · 2013-05-15Safety and Efficacy Trial of Bevacizumab: Anti-VEGF Humanized Monoclonal Antibody (NSC 704865) Therapy for Myelodysplastic Syndrome (MDS)
-
CLINICAL_TRIALS study record update · 2013-05-03A Phase II Trial of Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-05-01The Quality of Life of Adult Survivors Who Received a Marrow Transplant as a Child
-
CLINICAL_TRIALS study record update · 2013-04-24Pilot Study of 5 Azacytidine in the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukaemia With High-risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities
-
CLINICAL_TRIALS study record update · 2013-04-18Pharmacokinetics of Continuous Infusion Fentanyl in Cancer Patients
-
CLINICAL_TRIALS study record update · 2013-04-18An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)
-
CLINICAL_TRIALS study record update · 2013-04-05Phase II Clinical Evaluation of Bryostatin 1 in Patients With Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2013-04-04A Multicenter, Single-Arm, Open-Label Study of the Efficacy and Safety of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes